Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST)

被引:146
作者
Daniels, Marc [1 ]
Lurkin, Irene [2 ]
Pauli, Roland [3 ]
Erbstoesser, Erhard [4 ]
Hildebrandt, Uwe [5 ]
Hellwig, Karsten [6 ]
Zschille, Uwe
Lueders, Petra
Krueger, Gabriele
Knolle, Juergen
Stengel, Bernd
Prall, Friedrich [7 ]
Hertel, Kay [8 ]
Lobeck, Hartmut [9 ]
Popp, Brigitte
Theissig, Franz [10 ]
Wuensch, Peter [11 ]
Zwarthoff, Ellen [2 ]
Agaimy, Abbas [1 ]
Schneider-Stock, Regine [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany
[2] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
[3] Klinikum Brandenburg, Inst Pathol, Brandenburg, Germany
[4] AMEOS Klinikum St Salvator, Inst Pathol, Halberstadt, Germany
[5] Klinikum Quedlinburg, Inst Pathol, Quedlinburg, Germany
[6] Klinikum Magdeburg, Inst Pathol, Magdeburg, Germany
[7] Univ Rostock, Inst Pathol, D-2500 Rostock 1, Germany
[8] HELIOS Klin, Inst Pathol, Erfurt, Germany
[9] Ernst von Bergmann Klinikum, Inst Pathol, Potsdam, Germany
[10] Carl Thiem Klinikum, Inst Pathol, Cottbus, Germany
[11] Klinikum Nurnberg, Inst Pathol, Nurnberg, Germany
关键词
Gastrointestinal stromal tumor (GIST); KIT; Platelet derived growth factor receptor; alpha (PDGFRA); BRAF; PI3K; PIK3CA; V600E BRAF MUTATIONS; C-KIT; PDGFRA MUTATIONS; PHOSPHOINOSITIDE; 3-KINASE; JUXTAMEMBRANE DOMAIN; INTERSTITIAL-CELLS; POOR-PROGNOSIS; PRIMARY SITE; ASSOCIATION; MORPHOLOGY;
D O I
10.1016/j.canlet.2011.07.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Pathogenetic pathways of gastrointestinal stromal tumors (GIST) lacking mutations in KIT and PDGFRA (similar to 15%) are still poorly studied. Nearly nothing is known about PI3K alterations in GISTs and only a few GISTs with BRAF mutations have been reported. BRAF mutations (V600E) were found in 3/87 tumors (3.5%) concomitantly were wild type for KIT and PDGFRA. No mutations were detected in KRA.S, NRAS, and FGFR3. For the first-time we demonstrated a PIK3CA mutation (H1047L) simultaneously occurring with a 15-bp deletion in KIT exon 11 in one tumor. We suggest that BRAF mutations are of pathogenetic significance in wild type GISTs. The PI3K pathway should be assessed in future studies. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 54
页数:12
相关论文
共 47 条
[1]
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours [J].
Agaimy, A. ;
Terracciano, L. M. ;
Dirnhofer, S. ;
Tornillo, L. ;
Foerster, A. ;
Hartmann, A. ;
Bihl, M. P. .
JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (07) :613-616
[2]
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors [J].
Agaram, Narasimhan P. ;
Wong, Grace C. ;
Guo, Tianhua ;
Maki, Robert G. ;
Singer, Samuel ;
DeMatteo, Ronald P. ;
Besmer, Peter ;
Antonescu, Cristina R. .
GENES CHROMOSOMES & CANCER, 2008, 47 (10) :853-859
[3]
[Anonymous], CLIN CANC RES
[4]
Antonescu CR, 2003, CLIN CANCER RES, V9, P3329
[5]
Bilchik A, 2005, ARCH SURG-CHICAGO, V140, P547
[6]
Gastrointestinal stromal tumors express ras oncogene - A potential role for diagnosis and, treatment [J].
Blair, SL ;
Al-Refaie, WB ;
Wang-Rodriguez, J ;
Behling, C ;
Ali, MW ;
Moossa, AR .
ARCHIVES OF SURGERY, 2005, 140 (06) :543-547
[7]
The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[8]
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma [J].
Capodanno, Alessandra ;
Camerini, Andrea ;
Orlandini, Cinzia ;
Baldini, Editta ;
Resta, Maria Letizia ;
Bevilacqua, Generoso ;
Collecchi, Paola .
HUMAN PATHOLOGY, 2009, 40 (10) :1408-1417
[9]
PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib [J].
Corless, CL ;
Schroeder, A ;
Griffith, D ;
Town, A ;
McGreevey, L ;
Harrell, P ;
Shiraga, S ;
Bainbridge, T ;
Morich, J ;
Heinrich, MC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5357-5364
[10]
Biology of gastrointestinal stromal tumors [J].
Corless, CL ;
Fletcher, JA ;
Heinrich, MC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3813-3825